store at low temperature
store at -20°C
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 347.00 | |
2 mg | In stock | $ 476.00 | |
5 mg | In stock | $ 695.00 | |
10 mg | In stock | $ 1,090.00 | |
25 mg | In stock | $ 1,660.00 | |
50 mg | In stock | $ 2,230.00 | |
100 mg | In stock | $ 2,950.00 |
Description | Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC). |
In vivo | In vivo, Labetuzumab inhibits tumor growth following a single intravenous administration at a dose of 0.5 mg per rat [1]. |
Synonyms | IMMU-14, hMN-14, IMMU-100 |
Molecular Weight | N/A |
CAS No. | 219649-07-7 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Labetuzumab 219649-07-7 IMMU-14 hMN-14 IMMU-100 inhibitor inhibit